Sixty-three women discharged from hospital with a diagnosis of myocardial infarction and 189 control patients were studied. All were under 45 years of age at the time of admission. Current oral contraceptive use, heavy cigarette smoking, treated hypertension and diabetes, pre-eclamptic toxaemia, and obesity were all reported by, and type H hyperlipoproteinaemia was found more often in, patients with myocardial infarction than their controls. The relationship between myocardial infarction and oral contraceptives could not be explained in terms of an association between the use of these preparations and the other factors. The combined effect of the risk factors was clearly synergistic.
Introduction
Oral contraceptives are apt to produce arterial as well as venous thrombosis. 1 2Evidence about their role in myocardial infarction is, however, conflicting.3 Myocardial infarction is uncommon in young women, ' and little relevant information may be expected from any of the large prospective studies of this disease now in progress.5 6 We therefore undertook a retrospective study of women under 45 years of age who survived a myocardial infarction as this method offered the possibility of obtaining information direct from enough patients to enable a definite conclusion to be reached. Several other factors are known to cause the disease, or are suspected of doing so, and we studied them also to see whether oral contraceptives acted independently or synergistically.
Patients and Methods
Married women under 45 years of age who had been treated for myocardial infarction during were identified in the discharge records of hospitals in two of the 15 hospital regions of England and Wales. All hospitals which treated general medical and surgical patients and had more than 300 beds were included in the study provided that a satisfactory diagnostic index had been maintained. Altogether 84 patients were identified from the records of 24 hospitals. Patients were included only when the diagnosis satisfied the criteria of the World Health Organization.7 Sixteen of the patients had died in hospital and five had died subsequently. Only limited information could be obtained about these 21 patients and they were therefore excluded from the study. The ages of the remaining 63 patients ranged from 25 to 44 years, with a mean of 40-1 years. Fifty were classified according to the World Health Organization as having had "definite myocardial infarction," and 13 as having had "probable myocardial infarction." Nine had been admitted on a previous occasion for definite or suspected infarction.
Three other patients wele taken as controls for each patient with infarction. They were selected at random from women who had been dischaiged after tueatment for certain acute medical or surgical conditions or after certain elective surgical procedures, and matched each patient with infarction in tespect of marital status, five-year age group, and year of admission. The conditions from which the control patients suffered are listed in table I. The proportion of patients who had used oral contraceptives during the month before admission was significantly higher among the patients with infarction than among the controls (P <0 001) (table III) , as was the proportion of those who had used oral contraceptives at any time (P <001).There was no appreciable difference betvween the two groups, however, in the proportions who had used oral contraceptives only at some time in the past (10 3% compared with 1200%).
The relative risk of admission for myocardial infarction in women who had been using oral contraceptives in the previous month compared with that in women who had never used them is estimated from these figures to be 4 5 to 1. None of the nine women who had had a previous myocardial infarction had ever used oral contraceptives, but two or more of the other risk factors mentioned below were present in all of them. The 17 patients with infarction who had been using oral contraceptives during the month before admission (table III) between the two groups (2-46 and 2-30 respectively), but significantly more of the patients with infarction (8;16 %) than the controls (6; 5 %) had an index greater than 3 0 (P <0 05). The increased frequency of pre-eclampsia (30 0% compared with 11 2%) was not due to an increased number of pregnancies (see table VII).
No appreciable difference was recorded between the groups in the frequency of previous renal or thyroid disease. Information on previous psychiatric history was difficult to interpret and will be reported separately. Blood lipids were examined in 44 (70%) of the patients with infarction and 84 (48%) of the controls. The results, which are reported in detail elsewhere," showed that the mean levels of both serum cholesterol and serum triglyceride were substantially higher in the patients with infarction. Type IIa hyperlipoproteinaemia (cholesterol 6-9 mmol/l (267 mg/100 ml) or more)* or IIb (cholesterol 6 9 mmol/l or more and triglyceride 2-3 mmol/l (207 mg/100 ml) or more) was present in 18 (41 %) of the patients with infarction but in none of the controls. In contrast, hyperlipoproteinaemia of type IV occurred with almost equal frequency in both groups (6-8% and 8 3% respectively).
With the finding of so many associations it is necessary to consider whether any of them are secondary, arising because the risk factors are themselves interrelated. For example, in Britain oral contraceptive use is associated with cigarette smoking, 1213 and cigarette smoking is associated with myocardial infarction. It is therefore necessary to examine the data separately for different smoking categories. This is done in table VIII. The data confirm that heavy smokers tend to use oral contraceptives more often than light or non-smokers and show that the relationship between oral contraceptive use and myocardial infarction is present in each category. The numbers of observations in each category are, however, small and the differences between patients with infarction and controls are significant only when all the smoking categories are considered together (P <0 01). The relationship appears more pronounced in smokers than in non-smokers. Oliver's data are less conclusive in regard to four other factors that were less prevalent-premature menopause, obesity, diabetes mellitus, and use of oral contraceptives. The last two factors were found to be clearly related to the disease in our study and in a concomitant study by Mann and Inman.'0 Obesity also emerged as a risk factor in our study, but not premature menopause.
ORAL CONTRACEPTIVES
The association between myocardial infarction and oral contraceptives shown by these two studies is unlikely to be due to bias. There was no selection in the choice of cases (other than the necessity for survival), which was determined by strict diagnostic criteria and the area of hospitalization. The method of selecting the controls ensured that the patients in both groups were comparable for age, marital status, and year and hospital of admission, and they were found to be comparable in country of origin and social class. Some patients admitted to hospital for elective surgical procedures are advised to stop using oral contraceptives before admission, but none of our control patients had stopped using them in the three months before admission. Moreover, the frequency of oral contraceptive use by the control patients was the same as that found in a survey of contraceptive practice among women in England and Wales in 1970.21 22 In both studies the proportion of women aged 30-39 years who reported using oral contraceptives was 13-5%.
Whether the association is causal or reflects the association of oral contraceptive use with some other factor is more difficult to decide. Nevertheless, the significant relative-risk estimate, even when allowing for the other associated variables, and the relationship between the frequency of cases reported to the Committee on Safety of Medicines and the dose of oestrogen23 all argue in favour of a causal relationship. The finding that women on oral contraceptives who developed myocardial tThe fact that blood lipids were examined in only 84 (48%) of the control patients is unlikely to have influenced these estimates to any appreciable extent, as type II hyperlipoproteinaemia is normally uncommon in young women. In our series no case was found in any of the control patients from whom blood samples were obtained. infarction tended to have been using them longer than control patients with other, unrelated diseases20 may go some way to explaining why earlier case-control studies based on fewer cases failed to show a clear relationship. 24 25 If, however, as these findings suggest, the risk increases with prolonged use we might have expected to find an appreciable though somewhat smaller risk in women who had used oral contraceptives in the past but had stopped using them before the infarction occurred. The numbers are too small to exclude such a possibility, but neither this study nor that of Mann and Inman provides any evidence to support it.
The strong suggestion that the combined effect of risk factors is synergistic may have important practical implications for the use of oral contraceptives. The appreciable increase in relative risk in women with more than one risk factor for myocardial infarction suggests that other methods of contraception should be considered in such cases.
INCIDENCE OF MYOCARDIAL INFARCTION
We can make a rough estimate of the incidence of myocardial infarction (as determined by admission to hospital) both in the general population and in users of oral contraceptives from the data collected in the North-West Metropolitan Region, where the proportion of hospitals included in the study was greater than in the Oxford Region. The hospitals participating in the study contained about 57% of the female acute general medical beds in the North-West Metropolitan Region. An estimate for the Region of the number of married women aged 30-44 years admitted to hospital with non-fatal myocardial infarction during 1968-72 can therefore be made by multiplying the observed number of patients by 1-75, on the assumption that the beds covered in the study served 57% of the Region's population and that the admissions to these beds were representative of the whole Region. Similarly, an estimate can be made of the corresponding number of patients admitted in the Region who were currently taking oral contraceptives. If the data acquired from the controls are assumed to be representative of the general married population in the Region, an estimate can be made of the number of women taking oral contraceptives at any point in time. On this basis the yearly hospital admission rate for nonfatal myocardial infarction is 2-1 per 100 000 in married women aged 30-39 years who do not use oral contraceptives and 5-6 per 100 000 in married women who do. In the 40-44-year age group the rates are 9 9 and 56-9 per 100 000 respectively. The increased risk of hospital admission for myocardial infarction in women currently using oral contraceptives (2-7 times in the 30-39-year age group and 5-7 times in the 40-44-year age group) is similar to the increased risk of death from the condition estimated by Mann and Inman. '' Introduction Inman and Vessey's report to the Committee on Safety of Drugs on deaths from pulmonary embolism and coronary and cerebral thrombosis in women of childbearing age was published in 1968.1 In the cases of pulmonary embolism and cerebral thrombosis a strong relationship was found with the use of oral contraceptives when these disorders occurred in the absence of predisposing conditions. More of the women who died from coronary thrombosis in the absence of predisposing conditions had also been using oral contraceptives than would have been expected from the experience of the control group, but for this condition the difference was not quite significant and a definite association was considered not proved. Later studies2 3 were not conclusive and we thought it desirable to undertake a further investigation of deaths from myocardial infarction in 1973. Efforts were made to interview the general practitioners who had cared for the patients. In 15 cases either the women were not registered with any doctor or the coroner, hospital, or local executive council could not identify him, and the medical records of nine women had been lost and no other data source was available. A further 34 deaths were not investigated because the general practitioner could not be interviewed. Thus 58 (21%) of the 277 deaths could not be studied.
Selection of Cases
The remaining 219 deaths were investigated by the committee's medical field officers, as a result of which a further 66 cases were excluded. In 37 cases evidence for the diagnosis of myocardial infarction was thought to be inadequate. Deaths were included in the final analysis only when the diagnosis was substantiated by necropsy findings or a history of typical chest pain together with electrocardiographic or enzymatic confirmation as defined by the World Health Organization.4 In 23 cases (10-5%) a necropsy carried out after the death certificate had been completed or (less often) other evidence suggested that death was attributable to a different cause. A further six cases were excluded because the wrong sex, age, or year of death had been given on the certificate. The remaining 153 deaths provide the basis for this report. In 104 cases the diagnosis was substantiated at necropsy. Procedure Forty-eight members of the committee's staff of medical officers took part in the field work. During the investigation of each death one of them completed a questionnaire as fully as possible with the aid of the general practitioner and any other doctors who had attended the patient during her terminal illness. Since the general practitioner's records had usually been returned to the local executive council after the patient's death he was asked to retrieve them before being interviewed. These major sources of information were often supplemented by hospital case notes, family planning clinic records, necropsy reports, and court records supplied by a coroner.
